Your search returned 6 results.

Results
	1.	Phase II study of picoplatin as second-line therapy for patients with small-cell lung cancer. [electronic resource] by Eckardt, John R Bentsion, Dimitri L Lipatov, Oleg N Polyakov, Igor S Mackintosh, Frederick R Karlin, David A Baker, Gizelle S Breitz, Hazel B Producer: 20090514 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Axitinib Versus Sorafenib in First-Line Metastatic Renal Cell Carcinoma: Overall Survival From a Randomized Phase III Trial. [electronic resource] by Hutson, Thomas E Al-Shukri, Salman Stus, Viktor P Lipatov, Oleg N Shparyk, Yaroslav Bair, Angel H Rosbrook, Brad Andrews, Glen I Vogelzang, Nicholas J Producer: 20171023 In: Clinical genitourinary cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial. [electronic resource] by Hutson, Thomas E Lesovoy, Vladimir Al-Shukri, Salman Stus, Viktor P Lipatov, Oleg N Bair, Angel H Rosbrook, Brad Chen, Connie Kim, Sinil Vogelzang, Nicholas J Producer: 20140117 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Antitumor activity and safety of tivozanib (AV-951) in a phase II randomized discontinuation trial in patients with renal cell carcinoma. [electronic resource] by Nosov, Dmitry A Esteves, Brooke Lipatov, Oleg N Lyulko, Alexei A Anischenko, A A Chacko, Raju T Doval, Dinesh C Strahs, Andrew Slichenmyer, William J Bhargava, Pankaj Producer: 20120712 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer. [electronic resource] by Robert, Nicholas J Diéras, Véronique Glaspy, John Brufsky, Adam M Bondarenko, Igor Lipatov, Oleg N Perez, Edith A Yardley, Denise A Chan, Stephen Y T Zhou, Xian Phan, See-Chun O'Shaughnessy, Joyce Producer: 20110527 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Palbociclib and Letrozole in Advanced Breast Cancer. [electronic resource] by Finn, Richard S Martin, Miguel Rugo, Hope S Jones, Stephen Im, Seock-Ah Gelmon, Karen Harbeck, Nadia Lipatov, Oleg N Walshe, Janice M Moulder, Stacy Gauthier, Eric Lu, Dongrui R Randolph, Sophia Diéras, Véronique Slamon, Dennis J Producer: 20161219 In: The New England journal of medicine vol. 375 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)